Za’Nyia Kelly giving remarks for Earth Day
From Backyard Gardens to National Impact: How One Detroit Native is Leading the Fight Against Climate Change
April 23, 2024 14:52 ET | AmeriCorps
Detroit, Mich, April 23, 2024 (GLOBE NEWSWIRE) -- In a speech delivered ahead of an appearance by President Joe Biden, Detroit native, AmeriCorps member and environmental champion, Za’Nyia Kelly,...
Build the world you want to live in
Biden-Harris Administration Announces Major Steps to Stand Up Landmark American Climate Corps Initiative, Mobilizing the Next Generation of Climate Leaders
April 22, 2024 16:08 ET | AmeriCorps
Washington, DC, April 22, 2024 (GLOBE NEWSWIRE) -- As part of the Biden-Harris administration’s historic climate and environmental justice agenda, President Biden will announce today a suite of key...
HeartFlow Logo.png
HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease
March 26, 2024 14:00 ET | HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the leader in AI-driven healthcare technology, today announced the launch of the DECIDE Registry, the largest prospective...
AmeriCorps members in action
Biden-Harris Administration Announces New Agreement Between Seven Federal Agencies to Implement the American Climate Corps
December 19, 2023 13:30 ET | AmeriCorps
Washington, DC, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Today, the Biden-Harris administration is taking critical steps to advance the American Climate Corps, a landmark initiative announced by President...
Cardiometabolic Heal
Cardiometabolic Health Congress Hosts 2023 Women's Masterclass in California
June 29, 2023 11:00 ET | Cardiometabolic Health Congress
Boca Raton, FL, June 29, 2023 (GLOBE NEWSWIRE) -- Informed by topics most relevant to cardiometabolic health providers, medical education leader Cardiometabolic Health Congress (CMHC) has announced...
Global Advanced Driver Assistance Systems (ADAS) Market Size/Share Worth USD 81.17 Billion by 2032 at an 18.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
June 05, 2023 16:30 ET | Custom Market Insights
Austin, TX, USA, June 05, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Advanced Driver Assistance Systems (ADAS) Market Size, Trends and Insights By...
Elevar Logo for Common Use.png
Elevar Therapeutics to Present Clinically Supported Poster at AACR 2023 Demonstrating Rivoceranib as a Potent, and Most Selective, TKI for VEGFR-2
March 16, 2023 08:00 ET | Elevar Therapeutics
FORT LEE, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...
Esperion Logo (primary).png
CLEAR Outcomes Accepted as Late-Breaking Clinical Trial at ACC.23 Annual Scientific Session & Expo together with the World Congress of Cardiology (ACC.23/WCC)
December 19, 2022 16:15 ET | Esperion Therapeutics, Inc.
– Positive CLEAR Outcomes data to be presented as a Late-Breaking Clinical Trial (LBCT) at ACC.23/WCC on March 4, 2023 – – Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral...
QuisLex Fall Schedule to Feature In-Person and Virtual Events
September 08, 2022 09:16 ET | QuisLex
Calendar of forums and conferences includes speaking engagements and sponsorships of premier events including SOLID, CLOC, ACC and Consero legal forums NEW YORK, Sept. 08, 2022 (GLOBE NEWSWIRE) --...
Esperion Logo (primary).png
Esperion Announces Bempedoic Acid (NEXLETOL®) Recommended as Oral Non-Statin Therapy for LDL-Cholesterol Lowering in American College of Cardiology Expert Consensus Decision Pathway
August 26, 2022 08:16 ET | Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that bempedoic acid (NEXLETOL®) is now recommended as an important oral non-statin therapy for...